CRT costs modeled
This article was originally published in The Gray Sheet
Executive Summary
Cardiac resynchronization therapy "appears to be an economically meaningful treatment strategy," according to an economic impact analysis of CRT released Sept. 2 at the European Society of Cardiology Congress in Vienna. The model, developed on behalf of the Eucomed CRT Steering Committee, shows that CRT can save about $3,600 in hospitalization costs per patient in the first year, compared to standard heart failure drug therapy. Guidant, one of the contributors to the Eucomed study, expects to release a CRT economic impact analysis based on its COMPANION trial in 2004 (1"The Gray Sheet" April 7, 2003, p. 3)...